Sort
82,697 grants matching “vaccine development”
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,972,315Stephen C Harrison · Boston Children'S Hospital · P01 · FY2024 · AI
Understanding Papillomavirus Virion Proteins and Vaccines
$2,971,195John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Alabama-Clinical Trials Unit
$2,969,781Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2011 · AI
Novel Adenovirus Vector-Based Vaccines for HIV-1
$2,969,378Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
Complete Analysis of T cell Epitopes from Yellow Fever Virus
$2,969,117 · N01 · FY2009 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,969,015David S Stephens · Emory University · UM1 · FY2022 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$2,968,370Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2019 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$2,967,125Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$2,965,801Valerie Fremont · Quality Biological, Inc. · N01 · FY2020 · AI
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,961,826Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Phase II - Development of a Prophylactic Onchocerciasis Vaccine
$2,961,685Darrick Carter · Pai Life Sciences, Inc. · N44 · FY2019 · AI
SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT
$2,961,570Medical Research Council Of South Africa · U01 · FY2003 · AI
Lead Optimization and Preclinical Development of Human Nicotine-Specific mAbs
$2,960,853Matthew W Kalnik · Antidote Therapeutics, Inc. · R01 · FY2015 · DA
Hematopoietic Cell Transplantation for Malignancies
$2,960,503Stephen J Forma · Beckman Research Institute/City Of Hope · P01 · FY2006 · CA
The Immunobiology of Marrow Allografts for Leukemia
$2,959,846Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Mucosal Immunity, Vaccines and Microbiota Interplay in Humans and Animal
$2,959,127Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2009 · AI
SPORE in Prostate Cancer
$2,958,339Sloan-Kettering Institute For Cancer Res · P50 · FY2005 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA
$2,957,583Dana-Farber Cancer Institute · P01 · FY2000 · CA
Shared Resource Management
$2,957,539M. Celeste Simon · University Of Pennsylvania · P30 · FY2022 · CA
NIAID VIROLOGY QUALITY ASSURANCE
$2,956,406James Bremer · Rush University Medical Center · N01 · FY2014 · AI
China's Integrated Programs for Research on AIDS
$2,955,968National Center/Aids/Std Control/Prevent · U19 · FY2004 · AI
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$2,955,783Linda-Gail Bekker · University Of Cape Town · UM1 · FY2021 · AI
Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
$2,955,452Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Vaccination against mucosal HIV clade C transmission
$2,955,315Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2009 · AI
Cellular Immunity to Category A-C Viruses in Humans
$2,955,191Robert William Finberg · Univ Of Massachusetts Med Sch Worcester · U19 · FY2013 · AI